FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060244901> ?p ?o ?g. }

• W2060244901 endingPage "2468" @default.
• W2060244901 startingPage "2458" @default.
• W2060244901 abstract "Patient-specific induced pluripotent stem cells (iPSCs) represent a potential source for developing novel drug and cell therapies. Although increasing numbers of disease-specific iPSCs have been generated, there has been limited progress in iPSC-based drug screening/discovery for liver diseases, and the low gene-targeting efficiency in human iPSCs warrants further improvement. Using iPSC lines from patients with alpha-1 antitrypsin (AAT) deficiency, for which there is currently no drug or gene therapy available, we established a platform to discover new drug candidates and correct disease-causing mutation with a high efficiency. A high-throughput format screening assay, based on our hepatic differentiation protocol, was implemented to facilitate automated quantification of cellular AAT accumulation using a 96-well immunofluorescence reader. To expedite the eventual application of lead compounds to patients, we conducted drug screening utilizing our established library of clinical compounds (the Johns Hopkins Drug Library) with extensive safety profiles. Through a blind large-scale drug screening, five clinical drugs were identified to reduce AAT accumulation in diverse patient iPSC-derived hepatocyte-like cells. In addition, using the recently developed transcription activator-like effector nuclease technology, we achieved high gene-targeting efficiency in AAT-deficiency patient iPSCs with 25%-33% of the clones demonstrating simultaneous targeting at both diseased alleles. The hepatocyte-like cells derived from the gene-corrected iPSCs were functional without the mutant AAT accumulation. This highly efficient and cost-effective targeting technology will broadly benefit both basic and translational applications. Conclusions: Our results demonstrated the feasibility of effective large-scale drug screening using an iPSC-based disease model and highly robust gene targeting in human iPSCs, both of which are critical for translating the iPSC technology into novel therapies for untreatable diseases. (HEPATOLOGY 2013;57:2458–2468)" @default.
• W2060244901 created "2016-06-24" @default.
• W2060244901 creator A5006894100 @default.
• W2060244901 creator A5010093750 @default.
• W2060244901 creator A5013773397 @default.
• W2060244901 creator A5015479608 @default.
• W2060244901 creator A5028680767 @default.
• W2060244901 creator A5033092919 @default.
• W2060244901 creator A5034041619 @default.
• W2060244901 creator A5042415301 @default.
• W2060244901 creator A5050911555 @default.
• W2060244901 creator A5054955615 @default.
• W2060244901 date "2013-06-01" @default.
• W2060244901 modified "2023-10-16" @default.
• W2060244901 title "Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells" @default.
• W2060244901 cites W1968129027 @default.
• W2060244901 cites W1968140045 @default.
• W2060244901 cites W1970426263 @default.
• W2060244901 cites W1978880915 @default.
• W2060244901 cites W1980449150 @default.
• W2060244901 cites W1982360832 @default.
• W2060244901 cites W1984582197 @default.
• W2060244901 cites W1985494276 @default.
• W2060244901 cites W1988627620 @default.
• W2060244901 cites W1990774725 @default.
• W2060244901 cites W1995718960 @default.
• W2060244901 cites W1999068651 @default.
• W2060244901 cites W2005697206 @default.
• W2060244901 cites W2008731781 @default.
• W2060244901 cites W2025074364 @default.
• W2060244901 cites W2028369290 @default.
• W2060244901 cites W2032492315 @default.
• W2060244901 cites W2036632122 @default.
• W2060244901 cites W2048974398 @default.
• W2060244901 cites W2049991946 @default.
• W2060244901 cites W2050869877 @default.
• W2060244901 cites W2052961824 @default.
• W2060244901 cites W2054920939 @default.
• W2060244901 cites W2066830592 @default.
• W2060244901 cites W2071393490 @default.
• W2060244901 cites W2073377349 @default.
• W2060244901 cites W2076403167 @default.
• W2060244901 cites W2082131511 @default.
• W2060244901 cites W2087264052 @default.
• W2060244901 cites W2094898345 @default.
• W2060244901 cites W2098248120 @default.
• W2060244901 cites W2098985594 @default.
• W2060244901 cites W2100641053 @default.
• W2060244901 cites W2102993514 @default.
• W2060244901 cites W2116450149 @default.
• W2060244901 cites W2118661959 @default.
• W2060244901 cites W2124517950 @default.
• W2060244901 cites W2126774748 @default.
• W2060244901 cites W2130498948 @default.
• W2060244901 cites W2147802916 @default.
• W2060244901 cites W2151126374 @default.
• W2060244901 cites W2152917871 @default.
• W2060244901 cites W2154609728 @default.
• W2060244901 cites W2164512616 @default.
• W2060244901 cites W2166221624 @default.
• W2060244901 cites W2166550586 @default.
• W2060244901 cites W2167872699 @default.
• W2060244901 cites W2168245648 @default.
• W2060244901 cites W2184040332 @default.
• W2060244901 doi "https://doi.org/10.1002/hep.26237" @default.
• W2060244901 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3633649" @default.
• W2060244901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23325555" @default.
• W2060244901 hasPublicationYear "2013" @default.
• W2060244901 type Work @default.
• W2060244901 sameAs 2060244901 @default.
• W2060244901 citedByCount "216" @default.
• W2060244901 countsByYear W20602449012013 @default.
• W2060244901 countsByYear W20602449012014 @default.
• W2060244901 countsByYear W20602449012015 @default.
• W2060244901 countsByYear W20602449012016 @default.
• W2060244901 countsByYear W20602449012017 @default.
• W2060244901 countsByYear W20602449012018 @default.
• W2060244901 countsByYear W20602449012019 @default.
• W2060244901 countsByYear W20602449012020 @default.
• W2060244901 countsByYear W20602449012021 @default.
• W2060244901 countsByYear W20602449012022 @default.
• W2060244901 countsByYear W20602449012023 @default.
• W2060244901 crossrefType "journal-article" @default.
• W2060244901 hasAuthorship W2060244901A5006894100 @default.
• W2060244901 hasAuthorship W2060244901A5010093750 @default.
• W2060244901 hasAuthorship W2060244901A5013773397 @default.
• W2060244901 hasAuthorship W2060244901A5015479608 @default.
• W2060244901 hasAuthorship W2060244901A5028680767 @default.
• W2060244901 hasAuthorship W2060244901A5033092919 @default.
• W2060244901 hasAuthorship W2060244901A5034041619 @default.
• W2060244901 hasAuthorship W2060244901A5042415301 @default.
• W2060244901 hasAuthorship W2060244901A5050911555 @default.
• W2060244901 hasAuthorship W2060244901A5054955615 @default.
• W2060244901 hasBestOaLocation W20602449011 @default.
• W2060244901 hasConcept C104317684 @default.
• W2060244901 hasConcept C107459253 @default.
• W2060244901 hasConcept C126322002 @default.
• W2060244901 hasConcept C144501496 @default.

• next